Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 2/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.36 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11987365 | 1.00 | KDM4E (0.42) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL12892303 | 1.00 | KDM4E (0.42) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL18265969 | 1.00 | KDM4E (0.42) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL17248354 | 1.00 | KDM4E (0.42) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL11885215 | 1.00 | KDM4E (0.42) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL18265994 | 0.99 | KDM4E (0.41) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL16171578 | 0.99 | KDM4E (0.43) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL20706645 | 0.99 | KDM4E (0.41) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL20706764 | 0.99 | KDM4E (0.41) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL24173830 | 0.97 | KDM4E (0.42) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8895966-B2 | Material for organic electroluminescence element, and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-25 | — | — | US | disclosed |
| US-8895966-B2 | Material for organic electroluminescence element, and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-25 | — | — | US | disclosed |
| US-20130092905-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-04-18 | — | — | US | disclosed |
| US-20130092905-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130092905-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | LEF1, ORMDL3, CD99 | KDM4E 1369/4885MAPT 932/4885SMN1; SMN2 4200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.